The expression of molecular markers characterizing activity of the tumor process and metastases (proliferation marker Ki-67, angiogenesis marker CD34, and lymphangiogenesis markers podoplanin and LYVE-1) was assessed by immunohictochemical method in the primary tumor specimens collected during surgery for cutaneous melanoma (40 patients). Proliferative activity of the tumor tissue and volume density of peritumoral blood and lymph vessels increased with increasing tumor malignancy, which could indicate the risk of metastases.
This is a preview of subscription content, access via your institution.
References
Zenit-Zhuravleva EG, Lushnikova AA, Ponkratova DA, Tsyganova IV, Mikhailova IN, Cheremushkin EA, Vikhrova AS, Treschalina EM, Demidov LV, Mazurenko NN. Several genetic features of human metastatic cutaneous melanoma. Mol. Med. 2014;(4):54-67. Russian.
Gomes FG, Nedel F, Alves AM, Nör JE, Tarquinio SB. Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms. Life Sci. 2013:92(2):101-107.
Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology. 2011:118(12):2351-2360.
Kamyab-Hesari K, Mohtasham N, Aghazadeh N, Biglarian M, Memar B, Kadeh H. The expression of MMP-2 and Ki-67 in head and neck melanoma, and their correlation with clinicpathologic indices. J. Cancer Res. Ther. 2014:10(3):696-700.
Maurichi A, Miceli R, Camerini T, Mariani L, Patuzzo R, Ruggeri R, Gallino G, Tolomio E, Tragni G, Valeri B, Anichini A, Mortarini R, Moglia D, Pellacani G, Bassoli S, Longo C, Quaglino P, Pimpinelli N, Borgognoni L, Bergamaschi D, Harwood C, Zoras O, Santinami M. Prediction of survival in patients with thin melanoma: results from a multi-institution study. J. Clin. Oncol. 2014:32(23):2479-2485.
Pasquali S, van der Ploeg AP, Mocellin S, Stretch JR, Thompson JF, Scolyer RA. Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell Melanoma Res. 2013:26(3):326-337.
Pastushenko I, Vermeulen PB, Carapeto FJ, Van den Eynden G, Rutten A, Ara M, Dirix LY, Van Laere S. Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis. Br. J. Dermatol. 2014:170(1):66-77.
Xu X, Chen L, Guerry D, Dawson PR, Hwang WT, VanBelle P, Elder DE, Zhang PJ, Ming ME, Schuchter L, Gimotty PA. Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma. Clin. Cancer Res. 2012:18(1):229-237.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 161, No. 4, pp. 532-537, April, 2016
Rights and permissions
About this article
Cite this article
Bgatova, N.P., Lomakin, A.I., Fursov, S.A. et al. Expression of Molecular Markers of Angiogenesis, Lymphangiogenesis, and Proliferation Depending on the Stage of Skin Melanoma. Bull Exp Biol Med 161, 542–546 (2016). https://doi.org/10.1007/s10517-016-3456-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-016-3456-5
Key Words
- cutaneous melanoma
- angiogenesis
- lymphangiogenesis
- proliferation